@prefix lcsh: <http://www.yso.fi/onto/lcsh/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

lcsh:sh85003338 skos:broader lcsh:sh85005699 .
lcsh:sh85113841 skos:broader lcsh:sh85005699 .
lcsh:sh85010629 skos:broader lcsh:sh85005699 .
lcsh:sh85005628 skos:broader lcsh:sh85005699 .
lcsh:sh88002652 skos:broader lcsh:sh85005699 .
lcsh:sh85005699
  skos:broader lcsh:sh85005701, lcsh:sh85044226, lcsh:sh85084013, lcsh:sh85005714, lcsh:sh00006460 ;
  skos:altLabel "Competitive antagonists (Metabolism)"@en, "Metabolic antagonists"@en ;
  skos:inScheme <http://www.yso.fi/onto/lcsh> ;
  skos:closeMatch <http://data.bnf.fr/ark:/12148/cb119798491>, <http://d-nb.info/gnd/4142687-3> ;
  dc:created "1986-02-11T00:00:00"^^xsd:dateTime ;
  a skos:Concept ;
  skos:member lcsh:collection_LCSH_General, lcsh:collection_LCSHAuthorizedHeadings ;
  skos:notation "QP801.A" ;
  skos:prefLabel "Antimetabolites"@en .

lcsh:sh2012002721 skos:broader lcsh:sh85005699 .
lcsh:sh85084013
  skos:notation "QP171-QP177", "QH521" ;
  skos:prefLabel "Metabolism"@en ;
  a skos:Concept .

lcsh:sh85141258 skos:broader lcsh:sh85005699 .
lcsh:sh85000330 skos:broader lcsh:sh85005699 .
lcsh:sh85049647 skos:broader lcsh:sh85005699 .
lcsh:sh85005714
  skos:notation "RS431.A64", "RC271.C5" ;
  skos:prefLabel "Antineoplastic agents"@en ;
  a skos:Concept .

<http://d-nb.info/gnd/4142687-3> skos:closeMatch lcsh:sh85005699 .
<http://www.yso.fi/onto/lcsh> a skos:ConceptScheme .
<http://data.bnf.fr/ark:/12148/cb119798491> skos:closeMatch lcsh:sh85005699 .
lcsh:sh00006460
  skos:prefLabel "Metabolism"@en ;
  a skos:Concept .

lcsh:sh85044226
  skos:notation "QP601.5" ;
  skos:prefLabel "Enzyme inhibitors"@en ;
  a skos:Concept .

lcsh:sh2010007274 skos:broader lcsh:sh85005699 .
lcsh:sh85005789 skos:broader lcsh:sh85005699 .
lcsh:sh85005701
  skos:prefLabel "Antimitotic agents"@en ;
  a skos:Concept .